SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

A new study found that combining cognitive behavioral therapy (CBT) and a wakefulness medication significantly improved levels of fatigue in patients with multiple sclerosis (MS). The findings may ...

JT Lew, PharmD, MBA, highlights that the primary challenges for patients with multiple sclerosis (MS) in accessing prescribed medications include dealing with the shock of the diagnosis, navigating ...

A suboptimal approach to medication management can lead to potentially harmful health outcomes. Most psychiatric drugs have side effects, and if a patient is not aware of them, they may seek ...

"AI-assisted medication management represents a powerful opportunity for critical and timely healthcare transformation to improve patient care, health system margins, and providers' experiences, all ...

Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...